Zhaoming Ye
Welcome,         Profile    Billing    Logout  
 0 Trials 
14 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ye, Zhaoming
NCT03932071: Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma

Recruiting
4
150
RoW
Zoledronic Acid
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lung Metastases, Tumor Necrosis
01/20
01/23
MANEUVER, NCT05804045: Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor

Active, not recruiting
3
90
Europe, Canada, US, RoW
Pimicotinib(ABSK021), Placebo
Abbisko Therapeutics Co, Ltd
Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath
05/26
06/28
NCT05193188: A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma

Recruiting
2
70
RoW
Anlotinib hydrochloride, FuKeWei, PD-1 inhibitor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Chondrosarcoma
03/25
03/26
NCT05926492: A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma

Recruiting
2
160
RoW
Surufatinib plus chemotherapy, Arm A, Chemotherapy, Arm B
Second Affiliated Hospital, School of Medicine, Zhejiang University
Osteosarcoma
07/25
07/26
NCT05046314: A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma

Recruiting
2
30
RoW
TK216+Vincristin
Shanghai Pharmaceuticals Holding Co., Ltd
Sarcoma, Ewing
09/25
12/25
ARTEMIS-002, NCT05830123: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas

Recruiting
2
170
RoW
HS-20093
Hansoh BioMedical R&D Company
Osteosarcoma, Sarcoma
12/25
12/27
NCT05301764: A Study of LVGN6051 Combined with Anlotinib in Patient with Soft Tissue Sarcoma

Recruiting
1/2
65
RoW
LVGN6051 and Anlotinib
Lyvgen Biopharma Holdings Limited
Soft Tissue Sarcoma
03/25
10/25
NCT05944224: A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors.

Recruiting
1/2
63
RoW
SPH4336, Cadonilimab
Shanghai Pharmaceuticals Holding Co., Ltd
Advanced Solid Tumors
05/25
12/25
NCT05590572: A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma

Not yet recruiting
1/2
148
RoW
Sulfatinib, Etoposide, Isophosphamide
Second Affiliated Hospital, School of Medicine, Zhejiang University, Chonnam National University, Peking University People's Hospital, Qilu Hospital of Shandong University, Ruijin Hospital, Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Osteosarcoma
12/26
12/27
MASCT-I, NCT03034304: A Phase I Clinical Study for Evaluating the Safety and Efficacy of in Patients With Advanced Solid Tumors

Recruiting
1
193
RoW
MASCT-I, Ifosfamide, PD1 antibody, Adriamycin, Gemcitabine, Cisplatin, Carboplatin
SYZ Cell Therapy Co..
Advanced Solid Tumors
07/23
07/23
NCT04192344: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor

Recruiting
1
85
US, RoW
ABSK021
Abbisko Therapeutics Co, Ltd
Neoplasms, Tenosynovial Giant Cell Tumor
12/25
12/25
NCT06317480: Outcomes Comparison Between Bone Resection and Subperiosteal Dissection for Specific Type of Soft Tissue Sarcoma

Completed
N/A
142
NA
bone resection, subperiosteal excision
Second Affiliated Hospital, School of Medicine, Zhejiang University
Soft Tissue Sarcoma, Cortical Contact
05/20
09/23
NCT05735470: An Exploratory Clinical Trial to Evaluate the Efficacy and Safety of a Novel Antibacterial Bone Traction Needle

Recruiting
N/A
10
RoW
antibacterial bone traction needles
Second Affiliated Hospital, School of Medicine, Zhejiang University
Wound Infection
03/23
05/23
CORN, NCT05339425: Chinese Osteoporotic Fracture Registration Network Platform

Recruiting
N/A
50000
RoW
No additional intervention will be administered.
Peking Union Medical College Hospital, Xuanwu Hospital, Beijing, Beijing Hospital, Tianjin First Central Hospital, Hebei Medical University Third Hospital, Dalian Hospital of Chinese Traditional and Western Medicine, The Second Affiliated Hospital of Harbin Medical University, Peking University Third Hospital, Beijing Shijingshan Hospital, The Second Medical Center of The General Hospital of the People's Liberation Army, Huamei hospital, University of Chinese Academy of Sciences, Second Affiliated Hospital, School of Medicine, Zhejiang University, Shanghai 10th People's Hospital, Ruijin Hospital, The First People's Hospital of Changzhou, Affiliated Hospital of Nantong University, Nantong First People's Hospital, Shanghai Changzheng Hospital, Wuhan Union Hospital, China, Central South University, Guangdong Provincial People's Hospital, Nanfang Hospital of Southern Medical University, Lunjiao Hospital of Shunde Foshan, The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, First Affiliated Hospital of Fujian Medical University, Fuzhou Second Hospital, Second Affiliated Hospital of Guangzhou Medical University, Shenzhen Second People's Hospital, The Seventh Affiliated Hospital of Sun Yat-sen University, Sichuan Provincial People's Hospital, West China Fourth Hospital, Sichuan Province Orthopedic Hospital, The Second Affiliated Hospital of Chongqing Medical University, Daping Hospital, Army Medical Center of PLA, Guizhou Provincial Orthopedics Hospital, First Affiliated Hospital Xi'an Jiaotong University, Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region, The First Affiliated Hospital of Zhengzhou University
Osteoporosis, Osteoporotic Fractures
12/24
12/24

Download Options